Posted by Adam Bennett on Oct 11, 2012
One of the most important factors in determining the ultimate success of a next generation sequencing project is the initial project design. There are many things to consider when designing a project based on project goals, sample type, budget, timeframe etc. At EdgeBio we spend a great deal of time up front with our clients discussing and planning the best approach to meet their specific needs. For many clients this will be their first foray into the world of next generation sequencing and as the range of options continues to expand at a rapid pace it can be a daunting task in figuring
Genomics X Prize public phase: reference genome preparation and comparisons to Illumina and Complete GenomicsPosted by Brad Chapman on Sep 04, 2012
This is a guest post contributed by Dr. Brad Chapman from the Harvard School of Public Health. Original post can be found here.
Posted by Justin Johnson on Jun 04, 2012
It’s been a while since I have blogged on Ion Torrent data. There are several reasons for this.
First and foremost is that my head has been buried in The Archon Genomics XPrize Validation Protocol in which we were contracted to execute staring at the end of last year. The AGXP is an ambitious, incentivized prize competition that will award $10 million to the first team to rapidly, accurately, and economically sequence 100 whole human genomes to a level of accuracy never before achieved. The VP provides an opportunity to test and score current WGS technologies, assist the scientific community in establishing the reference genome(s) for this Competition and the means for analyzing the results of the Competition.
Second, it was with great anticipation and excitement that we received our Certificate of Compliance recently from the US Dept. of Health and Human Services Centers for Medicare and Medicaid Services. This means we have been deemed a CLIA lab and can begin to offer our Clinical Exome test under CLIA guidelines. No small feat.
But, here I am, again, knocking the dust off the blogging boots, and wading into another data set Ion Torrent has publically released.
Posted by Steven Davis on May 25, 2012
The Life Technologie's Ion Torrnet Bus stoped at EdgeBio in Gaithersburg, Maryland. Here they talked with President and CEO Dean Gaalaas about how EdgeBio has successfully been using the Ion PGM Sequencer in their service lab for over a year now. The Ion Torrent PGM Sequencer's speed has enabled EdgeBio to dramatically increase sequencing turnaround times, from weeks to days.
Posted by Justin Johnson on Apr 01, 2012
Contributed by Dr. Samuel Levy : Director of Genomic Sciences - Scripps Translational Science Institute and Scripps Genomic Medicine, Professor of Molecular and Experimental Medicine - The Scripps Research Institute
AmpliSeq Cancer Panel applied to a tumor and blood sample pair for the detection of common somatic mutations
We have a clinical research protocol that aims to provide tumor mutation data to oncologists as part of a patient’s cancer care within the Scripps network and we were trying to figure out ways of providing these data in a time sensitive manner to patients and their physicians. Whilst both exome and whole genome sequencing are good options, we wanted to maximize the use of any large amount of data we generate in an oncologist’s care approach. Consequently we decided that these options were data overkill for what a treating oncologist typically employs.
- April 2013 (1)
- February 2013 (1)
- January 2013 (1)
- December 2012 (1)
- November 2012 (7)
- October 2012 (3)
- September 2012 (1)
- August 2012 (3)
- June 2012 (2)
- May 2012 (2)
- April 2012 (6)
- March 2012 (3)
- February 2012 (4)
- January 2012 (4)
- December 2011 (2)
- November 2011 (3)
- October 2011 (3)
- September 2011 (2)
- August 2011 (1)
- June 2011 (4)
- May 2011 (1)
- November 2010 (2)
- October 2010 (1)
- September 2010 (3)
- August 2010 (2)